Skip to content

Listen Now

Threat Status podcast: Did Maduro pull off one of the most brazen election thefts in history?

Advertisement

Topic - Abbvie

AbbVie is a research-based pharmaceuticals company. - Source: Wikipedia

Related Stories

Photos

This photo provided by AbbVie shows the drug Mavyret. On Thursday, Aug. 3, 2017, the Food and Drug Administration approved Mavyret to treat all forms of hepatitis C. The drug works in as little as eight weeks and is for patients without significant cirrhosis who haven't been treated previously for the liver-destroying virus, plus patients who were not cured by a prior treatment. (Richard Mack/Courtesy of AbbVie via AP)

Quotations

AbbVie executives have said they expect to see possibly 10 biosimilar versions of Humira on the market by the second half of this year.

Cheaper competition for Humira is hitting the market, but savings will depend on your insurance →